🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to this year’s class of Conquer Cancer grant and award recipients! Are you one of them? Tell us in the comments! We can't wait to celebrate with you at #ASCO25. Full list of recipients: brnw.ch/21wSR0A ASCO

Excited to be back in Chicago for #ASCO2025 View from the CTA orange line on the train ride from the airport, my favorite mode of transportation in one of my favorite cities.

In general, sarcomas are rare and complex tumors. But they aren’t rare to MD Anderson experts. At 12:30 p.m. on Sunday, May 31, a group of sarcoma physicians will be in booth 10059 to share more about their latest research. #ASCO25 #EndCancer (7/10) Ryan Denu, MD, PhD Elise Nassif Haddad

Congrats to Mir Lim on an excellent presentation identifying differences in myeloid compartment and complement activation in MSI-H colorectal cancer MD Anderson Cancer Center #endcancer

Congrats to Stephanie presenting our work on optimal treatment of uterine #leiomyosarcoma #ASCO25 #endcancer MD Anderson Cancer Center

Congrats to Nakul Shah for an excellent presentation on MASLD affecting outcomes in biliary tract cancers MD Anderson Cancer Center #endcancer #ASCO25

Congrats to co-fellow Nirosha Perera on an excellent presentation on racial and environmental disparities in lung cancer patients. MD Anderson Cancer Center #ASCO25

Presented at #ASCO25: A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results:

Kudos to co-fellow Mitch Parma and Bingnan Zhang on a great presentation on tarlatamab real world experience in small cell lung cancer MD Anderson Cancer Center #ASCO2025 Kelsey Pan, MD, MPH #endcancer

Great to meet with our lung cancer experts at MD Anderson Cancer Center and thanks for the consult! Eric K. Singhi, MD Natalie Vokes #ASCO2025

Amazing work Mengjing Xiang improving our germline genetic testing rates for patients with cancer at our Houston county hospital, LBJ MD Anderson Cancer Center #ASCO2025 Harris Health Kelsey Pan, MD, MPH

Come check out Sankalp Arora, MD presenting on mechanisms of relapse after FLT3 inhibitor treatment in AML MD Anderson Cancer Center #endcancer #ASCO2025

Strong work form MD Anderson Cancer Center co-fellow Afsaneh Amouzegar, MD understanding KIT mutations and risk of CNS metastases in mucosal melanoma. #ASCO2025 #endcancer

PFS benefit with anlotinib+doxo and anlotinib maintenance. Lower than expected ORR in doxo arm and almost impossible to believe equivalence in toxicity between the arms. Same question as doxo+trabectedin: what if sequential single agent were used? #ASCO25

Exciting initial activity of TDXd in DSRCT. #ASCO25

Congrats Inimfon Jackson on a great presentation on disparities in chemotherapy delivery for breast cancer. Making us proud. #ASCO25 #endcancer MD Anderson Cancer Center

So proud of co-fellow Marija Sullivan, MD on a great presentation on real world implementation of Oncotype results. MD Anderson Cancer Center #ASCO25 #endcancer

We’re very proud of our MD Anderson Cancer Center heme/onc fellows Neha Akkad Nazli Dizman Cindy Y. Jiang Jen Marvin-Peek, MD Hila Shaim Inimfon Jackson Paulino Tallón de Lara MD, PhD Ranjan Upadhyay Michael Wotman Jenny Xiang Michael LaPelusa, MD Nakul Shah

Urging my representatives Senator Ted Cruz Senator John Cornyn Congressman Troy E. Nehls to oppose the congressional spending bill for many reasons, but as a physician, I’m most concerned about the additional 10.9 million people that would be left uninsured according to the CBO. #healthcareisahumanright

I know we're having fun, but imagine how much MORE fun it would be to live in a functioning democracy where two fragile billionaires crashing out didn't impact, say, rural hospital closures.